Seizert Capital Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Seizert Capital Partners, LLC

$2.14 Billion
Q4 2024

A detailed history of Seizert Capital Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Seizert Capital Partners, LLC holds 4,165 shares of VRTX stock, worth $1.91 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

4,165

Previous 10,711 61.11%

Holding current value

$1.91 Million

Previous $4.98 Million 66.33%

% of portfolio

0.08%

Previous 0.23%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$396.64 - $516.74 $2.6 Million - $3.38 Million	-6,546 Reduced 61.11%	4,165 $1.68 Million
Q3 2024 Nov 06, 2024	BUY	$460.0 - $505.78 $9,200 - $10,115	20 Added 0.19%	10,711 $4.98 Million
Q2 2024 Aug 07, 2024	SELL	$392.81 - $485.53 $575,859 - $711,786	-1,466 Reduced 12.06%	10,691 $5.01 Million
Q1 2024 May 01, 2024	SELL	$407.69 - $446.08 $169,191 - $185,123	-415 Reduced 3.3%	12,157 $5.08 Million
Q4 2023 Feb 07, 2024	SELL	$343.0 - $410.68 $1.65 Million - $1.98 Million	-4,823 Reduced 27.73%	12,572 $5.12 Million
Q3 2023 Nov 06, 2023	SELL	$338.18 - $362.46 $113,290 - $121,424	-335 Reduced 1.89%	17,395 $6.05 Million
Q2 2023 Jul 27, 2023	SELL	$314.42 - $351.91 $3.48 Million - $3.9 Million	-11,069 Reduced 38.44%	17,730 $6.24 Million
Q1 2023 May 09, 2023	SELL	$283.23 - $323.1 $2.15 Million - $2.45 Million	-7,582 Reduced 20.84%	28,799 $9.07 Million
Q4 2022 Jan 30, 2023	SELL	$285.76 - $321.48 $982,442 - $1.11 Million	-3,438 Reduced 8.63%	36,381 $10.5 Million
Q3 2022 Nov 02, 2022	SELL	$273.83 - $305.53 $45,181 - $50,412	-165 Reduced 0.41%	39,819 $11.5 Million
Q2 2022 Aug 04, 2022	SELL	$234.96 - $292.55 $22,086 - $27,499	-94 Reduced 0.23%	39,984 $11.3 Million
Q1 2022 May 03, 2022	BUY	$221.42 - $260.97 $327,701 - $386,235	1,480 Added 3.83%	40,078 $10.5 Million
Q4 2021 Feb 08, 2022	BUY	$177.01 - $223.45 $644,316 - $813,358	3,640 Added 10.41%	38,598 $8.48 Million
Q3 2021 Nov 03, 2021	BUY	$181.39 - $202.99 $181 - $202	1 Added 0.0%	34,958 $6.34 Million
Q2 2021 Aug 05, 2021	BUY	$187.49 - $221.1 $205,864 - $242,767	1,098 Added 3.24%	34,957 $7.05 Million
Q1 2021 May 05, 2021	BUY	$207.02 - $241.31 $7.01 Million - $8.17 Million	33,859 New	33,859 $7.28 Million

Others Institutions Holding VRTX

# of Institutions

1,745

Shares Held

227M

Call Options Held

1.53M

Put Options Held

1.4M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $118B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seizert Capital Partners, LLC with notifications on news.

Account

Seizert Capital Partners, LLC Vertex Pharmaceuticals Inc Transaction History